• Company
• Darzalex is granted reimb extension in Korea
• by Moon, sung-ho Jan 21, 2025 05:54am

• Company
• Only half of the multiple myeloma drugs reimb in KOR
• by Eo, Yun-Ho Jan 20, 2025 05:54am

• Policy
• Boryung’s Pomalyst generic first to be reimbursed in Korea
• by Lee, Tak-Sun Jan 20, 2025 05:54am

• Company
• Ziihera receives orphan drug designation in Korea
• by Eo, Yun-Ho Jan 20, 2025 05:54am

• Company
• [Reporter' View] Results from J.P. Morgan Conference
• by Lee, Seok-Jun Jan 20, 2025 05:53am

• Opinion
• [Reporter's View] Improving rare disease care environment
• by Eo, Yun-Ho Jan 17, 2025 05:54am

• Policy
• Drug expenditures surge due to the use of high-priced drugs
• by Lee, Tak-Sun Jan 17, 2025 05:53am

• Company
• Expanded reimb for 'Zejula'
• by Son, Hyung Min Jan 17, 2025 05:53am

• Policy
• Pulmonary fibrosis drug 'Ofev' under consideration for reimb
• by Lee, Tak-Sun Jan 17, 2025 05:53am

• Policy
• Innovative Pharmaceutical Company certification to change
• by Lee, Jeong-Hwan Jan 17, 2025 05:53am